Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obesity Control Through Leptogenic Drugs
NCT04443790Phase 2Completed
- Start
- Apr 2015
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 2, randomised trial in obesity and Leptin deficiency (CLD) (2 arms). Primary endpoints: Leptin Level at 3 months and Body Mass Index at 3 months. Started Apr 2015; status: completed.
02
Conditions
obesityLeptin deficiency (CLD)
Beyond the preview
Go deeper on NCT04443790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04443790.